Stock Information
Lyell Immunopharma Inc (LYEL)
Ticker Symbol: LYEL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $450.04 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -15.4086
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -90.52%
Latest News
-
Needham Reiterates Buy on Lyell Immunopharma, Maintains $44 Price Target
Thu, May 7, 2026 6:33 AM
-
Lyell Immunopharma: Q1 Earnings Snapshot
Wed, May 6, 2026 5:19 PM
-
Earnings Scheduled For May 6, 2026
Wed, May 6, 2026 5:03 PM
-
Lyell Immunopharma Q1 EPS $(1.10) Beats $(2.19) Estimate, Sales $2.000K Miss $4.400K Estimate
Wed, May 6, 2026 4:38 PM
-
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
Wed, May 6, 2026 4:07 PM
Key Financials
Financial data not available
